Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by drippingsnoton Sep 15, 2020 9:23pm
113 Views
Post# 31564971

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:2025 price target

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:2025 price target All valid points - excellent Snowball !

Problem is we're dealing with someone who's angry and he wants all of us to feel his pain.
Porky is that way too - but - he is looking for a $10 share price so he can exit.
Not sure what Benny's plan is - think he's sitting on the fence and will remain an investor - he's got no where he wants to go.

Benny feels the company should have spent the $800M earlier on. 
He feels the company missed opportunities along the way - like cancer drugs and cannabis companies.  He is upset that GUD didn't purchase large revenue generators a long time ago so he didn't have to wait.  Therefore, he feels cheated.  I just don't think he understands the kind of money that would have been needed to purchase some of those companies ... and their technologies were (are) unproven.

Goodman would never take a chance on unproven drug technology.  He'd lend them money for rights and he'd take their technology as collateral and he'd take their shares as a bonus.  He would never take ownership of risk.

It's just the way it is and there's nothing I can do (nothing any of us can do) to make Benny (and Porky for that matter) feel better.
Bullboard Posts